Table 4.
Type of PHID and PHID complications in 5 clusters of 79 PHID patients, ALTADIH Cohort, 2007-2010
| |
Cluster 1 |
Cluster 2 |
Cluster 3 |
Cluster 4 |
Cluster 5 |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
|
n = 33 |
n = 18 |
n = 4 |
n = 8 |
n = 16 |
||||||
| n | % | n | % | n | % | n | % | n | % | |
|
Type of PHID |
|
|
|
|
|
|
|
|
|
|
| CVID |
23 |
(70) |
8 |
(44) |
3 |
(75) |
8 |
(100) |
13 |
(82) |
| IgG subclass deficiency |
10 |
(30) |
10 |
(56) |
0 |
(0) |
0 |
(0) |
1 |
(6) |
| Good’s syndrome |
0 |
(0) |
0 |
(0) |
1 |
(25) |
0 |
(0) |
2 |
(12) |
|
PHID complications (at least one of the following) |
5 |
(15) |
6 |
(33) |
3 |
(75) |
7 |
(88) |
10 |
(63) |
| Lymphoid hyperplasia |
2 |
(6) |
5 |
(28) |
1 |
(25) |
3 |
(38) |
5 |
(31) |
| Splenomegaly |
1 |
(3) |
2 |
(11) |
1 |
(25) |
7 |
(88) |
3 |
(19) |
| Autoimmune manifestations |
3 |
(9) |
1 |
(5) |
1 |
(25) |
2 |
(25) |
7 |
(44) |
| Granulomatous disease |
0 |
(0) |
1 |
(5) |
2 |
(50) |
4 |
(50) |
2 |
(13) |
| Villous atrophy |
0 |
(0) |
2 |
(11) |
0 |
(0) |
0 |
(0) |
3 |
(19) |
| Chronic inflammatory intestinal disease | 0 | (0) | 2 | (11) | 1 | (25) | 1 | (13) | 0 | (0) |